Abstract
OBJECTIVE: To compare the use of medications in African-American and Caucasian elderly Medicare patients hospitalized with acute myocardial infarction (AMI) in Alabama.
DESIGN: Retrospective medical record review.
SETTING: All acute care hospitals in Alabama.
PATIENTS: All Medicare patients with a principal discharge diagnosis of AMI from June 1992 through February 1993. We excluded those patients less than 65 years of age and those of ethnicity other than African-American or Caucasian (N=4,052).
MEASUREMENTS: We first performed a crude analysis using all cases to compare by race the use of thrombolysis, β-adrenergic blockade, and aspirin in the setting of AMI. In addition, we developed a multivariable model with receipt of therapy as the outcome and demographics, severity of illness, comorbidity, and algorithm-determined candidacy for therapy as covariates. The algorithms, developed as part of the Cooperative Cardiovascular Project, were designed to identify an “ideal” pool of candidates for each therapy.
MAIN RESULTS: For all cases, 9.2% (95% confidence interval [CI] 6.8, 12.1) of African Americans received thrombolysis compared with 17.3% (95% CI 16.0, 18.6) of Caucasians. Approximately 16.4% of patients received β-adienergic blockade, and 45.1% received aspirin, both with no racial difference. By multivariate analysis, the adjusted odds ratio for African Americans receiving thrombolysis was 0.55 (95% CI 0.41, 0.76). The corresponding odds ratio was 1.25 (95% CI 0.99, 1.59) for p-adrenergic blockade and 1.13 (95% CI 0.96, 1.37) for aspirin. African Americans presented later after the onset of chest pain, but the refusal rate of thrombolytic therapy did not differ.
CONCLUSIONS: According to this analysis, Alabama physicians used β-adrenergic blockade and aspirin equivalently in African Americans and Caucasians. African Americans received thrombolysis less often according to the crude analysis. The multivariable analysis suggests less use of thrombolytics, even after adjusting for several covariates including indication by clinical algorithm. However, the small number of African-American patients deemed ideal candidates for thrombolysis attenuates the precision of this finding.
Similar content being viewed by others
References
Cooper RS, Ghali JK. Coronary heart disease: black-white differences. Cardiovasc Clin. 1991;21(3):205–25.
Giles WH, Anda RF, Casper ML, et al. Race and sex differences in rates of invasive cardiac procedures in US hospitals. Arch Intern Med. 1995;155(3):318–24.
McBean AM, Warren JL, Babish MD. Continuing differences in the rates of percutaneous transluminal coronary angioplasty and coronary artery bypass graft surgery between elderly black and white Medicare beneficiaries. Am Heart J. 1994;127(2):287–95.
Franks AL, May DS, Wenger NK, et al. Racial differences in the use of invasive coronary procedures after acute myocardial infarction in Medicare beneficiaries. Ethn Dis. 1993;3(3):213–20.
Udvarhelyi IS, Gatsonis C, Epstein AM, et al. Acute myocardial infarction in the Medicare population. Process of care and clinical outcomes. JAMA. 1992;268(18):2530–6.
Goldberg KC, Hartz AJ, Jacobsen SJ, et al. Racial and community factors influencing coronary artery bypass graft surgery rates for all 1986 Medicare patients. JAMA. 1992;267(11):1473–7.
Whittle J, Conigliaro J, Good CB, et al. Racial differences in the use of invasive cardiovascular procedures in the Department of Veterans Affairs medical system. N Engl J Med. 1993;329:621–7.
Lau J, Antman EM, Jimenez-Silva J, et al. Cumulative meta-analy-sis of therapeutic trials for myocardial infarction. N Engl J Med. 1992;327:248–54.
Ellerbeck EF, Jencks SF, Radford MJ, et al. Quality of care of Medicare patients with acute myocardial infarction. JAMA. 1995;273(19):1509–14.
Gunnar RM, Bourdillon PD, Dixon DW, et al. Guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Vascular Procedures (Subcommittee to Develop Guidelines for the Early Management of Patients with Acute Myocardial Infarction). J Am Coll Cardiol. 1990;16:249–92.
Rosner BA. Fundamentals of Biostatistics. Boston, Mass: Duxbury Press; 1995.
Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373–83.
Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613–9.
Iezzoni LI. Risk Adjustment for Measuring Health Outcomes. Ann Arbor, Mich: Health Administration Press; 1994.
Ford ES, Cooper RS. Racial/ethnic differences in health care utilization of cardiovascular procedures: a review of the evidence. Health Serv Res. 1995;30(1):237–52.
Peterson ED, Wright SM, Daley J, et al. Racial variation in cardiac procedure use and survival following acute myocardial infarction in the Department of Veterans Affairs. JAMA. 1994;71(15):1175–80.
Kahn KL, Pearson ML, Harrison ER. Health care for black and poor hospitalized Medicare patients. JAMA. 1994;271(15):1169–74.
Pashos CL, Norman ST. Garfinkle JB. Trends in the use of drug therapies in patients with acute myocardial infarction: 1988 to 1992. J Am Coll Cardiol. 1994;23:1023–30.
Maynard C, Litwin RE, Martin JS, et al. Characteristics of black patients admitted to coronary care units in metropolitan Seattle: results from the Myocardial Infarction Triage and Intervention Registry (MITI). Am J Cardiol. 1991;67(1):18–23.
Taylor HA, Chaitman BR, Rogers WJ, et al. Race and prognosis after myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial. Circulation. 1993;88:1484–94.
Ell K, Haywood LJ, Sobel E, et al. Acute chest pain in African Americans: factors in the delay in seeking emergency care. Am J Public Health. 1993;84(6):965–70.
Gahli JK, Cooper RS, Kowatly I, et al. Delay between onset of chest pain and arrival to the coronary care unit among minority and disadvantaged patients. J Nail Med Assoc. 1993;85:180–4.
Clark LT, Bellam SV, Shah AH, et al. Analysis of prehospital delay among inner-city patients with symptoms of myocardial infarction: implications for therapeutic intervention. J Natl Med Assoc. 1992;84(11):931–7.
Raczynski JM, Taylor H, Cutter G, et al. Diagnoses, symptoms, and attributions of symptoms among black and white inpatients admitted for coronary heart disease. Am J Public Health. 1994;84(6):951–6.
Vaitkus PT. Percutaneous transluminal coronary angioplasty versus thrombolysis in acute myocardial infarction: a meta-analysis. Clin Cardiol. 1995;18(1):35–8.
Author information
Authors and Affiliations
Additional information
Received from the Division of General Internal Medicine and the Division of Preventive Medicine, University of Alabama at Birmingham School of Medicine, and Alabama Quality Assurance Foundation (AQAF).
This paper expresses solely the opinion of the authors, and not that of the Health Care Financing Administration.
This research was supported in part by Agency for Health Care Policy and Research Grant #1 U18 HS-9446.
Rights and permissions
About this article
Cite this article
Allison, J.J., Kiefe, C.I., Centor, R.M. et al. Racial differences in the medical treatment of elderly medicare patients with acute myocardial infarction. J Gen Intern Med 11, 736–743 (1996). https://doi.org/10.1007/BF02598987
Issue Date:
DOI: https://doi.org/10.1007/BF02598987